Therapeutic factors considered according to the preoperative splenic volume for a prolonged increase in platelet count after partial splenic embolization for liver cirrhosis

J Gastroenterol. 2010 May;45(5):554-9. doi: 10.1007/s00535-009-0185-9. Epub 2010 Jan 5.

Abstract

Purpose: Infarcted splenic volume has been identified as the predictive factor for a prolonged increase in platelet count after partial splenic embolization (PSE). However, despite enough infarcted splenic volume, some patients show only a slight increase in platelet counts after PSE because of rapid regrowth of the noninfarcted splenic parenchyma within several months post-PSE. The purpose of this study was to determine the therapeutic factors based on the preoperative splenic volume for a prolonged increase in platelet counts after PSE.

Methods: In 72 cirrhotic patients with follow-ups longer than 1 year post-PSE, depending on the preoperative splenic volume, the splenic factors associated with a prolonged increase in platelet counts at 1 year after PSE were retrospectively examined.

Results: In 57 patients with preoperative splenic volumes <or=700 ml, the preoperative splenic volume (P = 0.001), infarcted splenic volume (P < 0.001), and splenic infarction ratio (P = 0.001) showed positive correlations with increments in platelet counts at 1 year post-PSE. In 15 patients with preoperative splenic volumes >700 ml, noninfarcted splenic volume (P = 0.003) and splenic infarction ratio (P = 0.002) showed negative and positive correlations with the increment in platelet counts at 1 year post-PSE, respectively.

Conclusions: In patients with splenic volumes <or=700 ml, the infarcted splenic area significantly affects the prolonged increase in platelet counts post-PSE. In patients with splenic volumes >700 ml, the noninfarcted splenic area is significant.

MeSH terms

  • Adult
  • Aged
  • Cohort Studies
  • Embolization, Therapeutic*
  • Female
  • Humans
  • Hypersplenism / blood
  • Hypersplenism / pathology
  • Hypersplenism / therapy*
  • Liver Cirrhosis / blood*
  • Liver Cirrhosis / pathology*
  • Liver Cirrhosis / therapy
  • Male
  • Middle Aged
  • Organ Size
  • Platelet Count
  • ROC Curve
  • Retrospective Studies
  • Risk Factors
  • Splenectomy
  • Splenic Infarction / blood
  • Splenic Infarction / pathology
  • Splenic Infarction / therapy*
  • Thrombocytopenia / etiology
  • Thrombocytopenia / pathology
  • Thrombocytopenia / prevention & control*